drugset / Trial / NCT02742649

A Study to Evaluate Efficacy and Safety of a Fixed Combination Ocular Insert in Participants With Open-angle Glaucoma or Ocular Hypertension

NCT02742649

Phase 1/2 Completed 55 enrolled ForSight Vision5, Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine if a combination of two drugs (bimatoprost and timolol) delivered to the surface of the eye over 10 weeks is better at lowering intraocular pressure (IOP) than either of the drugs delivered alone.

Timeline

Start
2016-04-30
Primary completion
2016-12-31
Completion
2016-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Bimatoprost Other / unclassified Topical
Subject Timolol Other / unclassified 0.5 % Topical